DBV Technologies SA - ADR DBVT shares are trading lower by $22.00 (46 percent) at $26.07 in Monday's session.
Before the open, the company announced that a peanut allergy trial failed to meet its primary endpoint.
After a much lower, DBV continued in that direction before finally finding a bottom at $22.33 and reversed course. That low matches it Feb. 2016 low of $22.55. Since reaching that depressed level, it has continued to make new highs for the session. As of 11:35 a.m. ET, the high stands at $26.82.
Today's decline is taking place o much heavier than average volume, as over 8 million shares have traded compared to its 20-day average of 670,000.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.